Drug Information

Drug General Information
Drug ID
D01HKZ
Former ID
DIB004927
Drug Name
TSR-011
Indication Non-small cell lung cancer [ICD10:C33-C34] Phase 1/2 [524619]
Company
Tesaro
Target and Pathway
Target(s) ALK tyrosine kinase receptor Target Info Inhibitor [532061], [550510]
KEGG Pathway Non-small cell lung cancer
WikiPathways Differentiation Pathway
References
Ref 524619ClinicalTrials.gov (NCT02048488) A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas. U.S. National Institutes ofHealth.
Ref 532061Treatment of ALK-positive non-small cell lung cancer. Arch Pathol Lab Med. 2012 Oct;136(10):1201-4.
Ref 550510National Cancer Institute Drug Dictionary (drug id 757983).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.